Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2025

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Las Vegas Technology and Innovation Conference

Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company advancing treatments for neurodegenerative diseases such as ALS and MS, will participate in the Jones Las Vegas Technology and Innovation Conference on April 8–9, 2025. Held at The Venetian Resort, the event will feature … Continue reading

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Taps IBN to Lead Corporate Communications Strategy

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, has selected IBN to manage its corporate communications and investor outreach. Soligenix is advancing late-stage clinical programs through its oncology and inflammation-focused Specialized BioTherapeutics segment and its Public Health Solutions … Continue reading

Posted in Small Cap News | Leave a comment

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Helping Pioneer Lithium-Sulfur Battery Technology

The global demand for efficient, high-capacity energy storage solutions has intensified, propelling advancements in battery technology to the forefront of scientific and industrial innovation. Among the emerging contenders, lithium-sulfur (“Li-S”) batteries have garnered significant attention for their potential to surpass … Continue reading

Posted in Platinum Group Metals Ltd. PLG | Leave a comment

Newton Golf Company (NASDAQ: NWTG) ‘Pioneering New Era’ in Growing Golf Equipment Market

The global golf equipment market is experiencing significant growth, driven by increasing participation and technological advancements. This upward trend presents substantial opportunities for companies operating within the golf-equipment sector, such as Newton Golf Company (NASDAQ: NWTG), a technology-forward golf equipment manufacturer … Continue reading

Posted in Newton Golf Comp. NWTG | Leave a comment

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Unveils Progress on CNM-Au8(R), Eyes Potential Fast-Track FDA Approval

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is actively advancing … Continue reading

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial Results

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced its recent accomplishments and financial results for the year ended Dec. 31, 2024. “We … Continue reading

Posted in Soligenix Inc. SNGX | Leave a comment

Thumzup Media Corp. (NASDAQ: TZUP) Boosts Shareholder Value with Share Buyback

Social media branding and marketing innovator Thumzup (NASDAQ: TZUP) continues building, helping shareholders after its uplisting to the Nasdaq exchange, announcing recently that board members have approved a stock buyback program of up to $1 million in shares and the company has … Continue reading

Posted in Thumzup Media Corp. TZUP | Leave a comment

MissionIRNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Fuels Explosive Growth with Disruptive AdTech Platform

Thumzup (NASDAQ: TZUP) is leveraging its proprietary social media marketing platform, AdTech, which drives influencers to catapult the effectiveness of small-business advertising. Having achieved a growth rate of over 200% CAGR, Thumzup now serves more than 700 clients, with projections to … Continue reading

Posted in Thumzup Media Corp. TZUP | Leave a comment

Clene Inc.’s (NASDAQ: CLNN) CNM-Au8(R) Delivers Significant Survival Benefits in New Analyses of Healey ALS Platform Trial Data

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), has released … Continue reading

Posted in Clene Inc. CLNN | Leave a comment

MissionIRNewsBreaks – Why Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. “Operating through two key segments, the company’s Specialized BioTherapeutics division is dedicated to oncology and inflammation therapies, while its … Continue reading

Posted in Soligenix Inc. SNGX | Leave a comment